Whisone AnalystInvestor workspace
FIDSONHealthcareUpdated 3h ago

FIDSON

FIDSON (FIDSON) is listed on the Nigerian Exchange in the Healthcare sector, with exposure to Pharmaceutical Preparations. This page brings together the current share price, valuation, dividend context, business summary, and a practical 12-week outlook so you can assess the stock faster.

Sector

Healthcare

Market cap

₦239B

Dividend yield

1.5%

P/E ratio

24.16

Current price

₦99.50

Updated Updated 3h ago

Wait (12-week)

12-week outlook signal

Research score55/100

P/B

7.91

RSI

54.97

52W high

₦105.35

52W low

₦19.00

Valuation view

Priced richer than peers

Income view

Low income profile

Momentum view

Momentum is balanced

Risk view

Lower volatility profile

Business trend

Latest operating data is available

Fidson makes and supplies pharmaceutical preparations, including medicines and healthcare products. It earns money by selling those products to hospitals, pharmacies, retailers and other customers, generating revenue from product sales and distribution.

Investors usually follow FIDSON for its dividend profile, valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.

Why this stock stands out

What looks attractive right now.

Return on equity is healthy at roughly 32.7%, which suggests the business is using shareholder capital well.

Latest revenue

₦119B

Most recent reported period.

Latest net profit

₦9.88B

Most recent reported period.

ROE

32.7%

Return on equity

Debt / equity

1.11

Lower is usually safer.

P/B ratio

7.91

Useful for book value support.

Dividend yield

1.5%

Current income signal.

Explain the key numbers

P/E ratio

24.16

Price-to-earnings shows what investors pay for every ₦1 of profit. Lower can signal cheaper valuation, but only if profits are reliable.

Compare P/E with peers in the same sector to avoid false signals.

₦1.50

2026-04-15

Payment: 2026-07-31 · Qualification: 2026-04-14

₦1.00

2025-07-14

Payment: 2025-08-01 · Qualification: 2025-07-11

₦0.60

2024-06-19

Payment: 2024-07-05 · Qualification: 2024-06-18

₦0.55

2023-07-10

Payment: 2023-09-12 · Qualification: 2023-07-07

Watch the latest corporate action: Estimated earnings date.
Fundamentals were last updated 0 day(s) ago, so the next filing matters.
Monitor leverage discipline. Debt-to-equity is currently about 1.11x.

Estimated earnings date

2026-05-05

Estimated earnings date

2026-04-28

Ex-dividend date

2026-04-15

Price and session

Current price
₦99.50?
Open
₦99.50?
Previous close
₦95.10?
Day range
₦99.50 – ₦99.50?
52-week range
₦19.00 – ₦105.35?

Volume & liquidity

Today volume
848,232?
Average volume
730,371?
Volume vs average
1.16x?
Avg turnover/day
N/A
Tradeability
Easy to trade

Valuation

Market cap
₦239B?
P/E
24.16?
Forward P/E
14.61?
P/B
7.91?
Book value/share
12.58?

Momentum

Beta
0.72?
RSI
54.97?

Income & dividend

EPS
4.12?
Dividend yield
1.5%?
Dividend/share
₦1.50?
Ex-dividend date
2026-04-15?
Dividend records
6?

Latest financials

Revenue
₦119B?
Operating profit
₦28.1B?
Net income
₦9.88B
Operating cash flow
₦16.8B?
Capex
-₦8.02?

Event data

Estimated earnings date
2026-05-05

FIDSON

FIDSON

Price: ₦99.50

P/E: 24.16

Yield: 1.51%

AUSTINLAZ

AUSTINLAZ

Price: ₦3.73

P/E: N/A

Yield: N/A

MAYBAKER

MAYBAKER

Price: ₦39.35

P/E: 15.30

Yield: 1.02%

MCNICHOLS

MCNICHOLS

Price: ₦6.06

P/E: 19.54

Yield: 0.61%

Price updated

0d ago

Fundamentals updated

0d ago

Market cap

₦239B

Open

₦99.50

Previous close

₦95.10

Day range

₦99.50 – ₦99.50

52-week range

₦19.00 – ₦105.35

Volume

848,232

Average volume

730,371

Forward P/E

14.61

Beta

0.72

RSI

54.97

Latest revenue

₦119B

Latest net profit

₦9.88B

Book value / share

12.58

TradeabilityEasy to trade

At least one liquidity signal is strong now, though large orders should still be staged.

Compare mode →AI Expert analysis →

Login to use AI Analyst.

Main risks

No single balance-sheet or earnings red flag stands out immediately, but this still needs peer and filing context.